Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
Categories
RSS

Media

Medical Professionals Advocating for Continued Access to 503A Compounding Pharmacy Drugs at the California Board of Pharmacy’s Subcommittee Regulation Hearing
Medical Professionals Advocating for Continued Access to 503A Compounding Pharmacy Drugs at the California Board of Pharmacy’s Subcommittee Regulation Hearing

On June 18th, the California Board of Pharmacy (CA BOP) held a regulation hearing on compounded drug preparations. McGuff’s management team, along with an estimated attendance of over 100 people, including medical professionals from diverse specialties, attended this three-hour subcommittee meeting. Their goal was to advocate for continued access to sterile compounded drugs from 503A compounding pharmacies.